Sam is the Policy Research Lead at the Global Strategy Lab’s Antimicrobial Resistance Policy Accelerator. His previous policy and research experience focused on antimicrobial resistance containment strategies, access to medicines, and medicines for children.
Sam has consulted for the Fleming Fund on One-Health antimicrobial consumption in Pakistan; the Bayelsa State Drug Distribution Company on Medicines Quality Assurance in Nigeria; and WHO, as well as led or collaborated on projects in Bangladesh, Jordan, South Africa, and Yemen. A pharmacist and academic, he has also taught and supervised students in Nigeria and the UK.